Skip to content

Systematic Use of Telepsychiatry for Outpatients

Systematic Use of Telepsychiatry for Outpatients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05516238
Enrollment
34
Registered
2022-08-25
Start date
2021-04-21
Completion date
2022-04-26
Last updated
2023-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Borderline Personality Disorder, Depressive Disorder, Ptsd

Brief summary

Implementation and evaluation of video consultation in psychiatric outpatient treatment. The study will focus on patients' experiences regarding the use of VC. The study will also examine important aspects of the telepsychiatric consultation such as therapeutic alliance, consultation content, psychopathology and satisfaction levels compared to face-to-face consultations.

Interventions

OTHERCase management

Case management cover therapy (psychotherapy/psychoeducation), medication adjustment, training in daily living skills (supportive), and direct consultations in crises.

Sponsors

Psychiatric Research Unit, Region Zealand, Denmark
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age \> 18 years * Danish-speaking.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
The demand for video consultation (VC) in clinical practice.One yearThe demand for VC is evaluated by the percentage of included participants who chose to be in the VC group and the actual use of VC consultation sessions during the study period, including the number of missed appointments and the number of times VC sessions have been converted to telephone or in-person (IP) consultations.
Patients' therapeutic alliance, assessed by working alliance inventory- client version (WAI-C)Two months.Therapeutic alliance is evaluated with the mean change scores in the WAI-C questionnaire at baseline and posttreatment. Score ranging: from 12 to 84. Higher scores indicate a higher therapeutic alliance
Patients' satisfaction, assessed by client satisfaction questionnaire 8 (CSQ-8)Two months.Satisfaction is evaluated with the mean change scores in the CSQ-8 questionnaire at baseline and posttreatment. Score ranging: from 8 to 32. Higher scores indicate a higher satisfaction
Patients' Symptom level, assessed by Symptom Checklist -10 (SCL-10)Two months.Symptom level is evaluated with the mean change scores in the SCL-10 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Lower score indicates lower psychological distress
Patients' well-being, assessed by World Health Organisation- Five Well-Being Index (WHO-5)Two months.Well-being level is evaluated with the mean change scores in the WHO-5 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Higher scores indicate higher well-being
Patients' function, assessed by Sheehan Disability Scale (SDS)Two months.Functional impairment is evaluated with the mean change scores in the SDS questionnaire at baseline and posttreatment. Score ranging: from 0 to 30. lower scores indicate lower functional impairment
Patient recovery, assessed by INSPIRETwo months.Patient recovery is evaluated with the mean change scores in the INSPIRE questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. A higher score indicates higher recovery
The implementation and integration of VC in clinical practice, as assessed by a checklist developed for the case managers (CM).One yearThe following properties are used to evaluate the implementation and integration properties: 1. type of technology patients use for VC sessions (Smartphone/tablet or personal computer/laptop) 2. patients' physical location during VC session (Home or outdoor) 3. the VC sessions confidentiality (Alone or with other persons) 4. duration of VC session 5. the content of the VC sessions (supportive, therapy, medication management, crisis/acute or mix content) Descriptive statistics will be applied to evaluate the implementation and integration properties.
Patients' experiences regarding the use of VCTwo monthsSemistructured interviews have been conducted to evaluate participants' experience regarding the use of VC technology in clinical practice.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026